Anti-VEGF sheep monoclonal antibody - KS Biomedix Holdings

Drug Profile

Anti-VEGF sheep monoclonal antibody - KS Biomedix Holdings

Alternative Names: Anti-VEGF sheep monoclonal antibody

Latest Information Update: 14 May 2001

Price : $50

At a glance

  • Originator KS Biomedix Holdings; Nonindustrial source
  • Class Antineoplastics; Monoclonal antibodies
  • Mechanism of Action Vascular endothelial growth factor A inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Solid tumours

Most Recent Events

  • 14 May 2001 Discontinued-Preclinical for Solid tumours in United Kingdom (Unknown route)
  • 17 Oct 2000 The sheep monoclonal antibody to vascular endothelial growth factor is available for licensing (http://www.ksbiomedix.com)
  • 16 Dec 1997 Preclinical development for Solid tumours in United Kingdom (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top